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Abstract
A number of epidemiological studies have shown a strong association between exposure to ambient 
airborne particulate matter (PM 2.5, PM < 1.0) and lung or cardiovascular diseases characterised by 
high mortality and morbidity. However, much less is known about the role of air pollution in the patho-
genesis of autoimmune diseases, which constitutes a significant problem in modern society.
This paper summarises the state of current research regarding the influence of PM on the develop-
ment and/or progression of autoimmune diseases. A brief review of the great body of research concern-
ing pathogenesis of autoimmune disorders is presented. Then, the scope of our review is narrowed to 
the research related to the impact of particulate matter on oxidative and nitrosative stress, as well as 
exacerbation of chronic inflammation, because they can contribute to the development of autoimmune 
diseases. Moreover, we discuss the impact of various components of PM (metal, organic compounds) 
on PM toxicity and the ability to generate oxidants.
Key words: inflammation, oxidative stress, air pollution, particulate matter, autoimmune disease, 
nitrosative stress.
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Introduction
The detrimental health effect of the exposure to par-
ticulate matter (PM) present in air pollution has been 
documented in numerous studies [1, 2]. Epidemiological 
evidence indicates that poor air quality contributes to in-
creased morbidity and mortality due to several reasons. 
Primarily, chronic exposure to PM increases the risk and 
is associated with progression of lung and cardiovascu-
lar diseases [3]. Production of oxidants, either directly by 
components of PM or by the host response to air pollution, 
seems to be the major biological effect responsible for tis-
sue injury, and a local as well as systemic inflammatory 
response [4]. The question arises whether oxidative stress 
induced by exposure to PM contributes to an increased risk 
and/or pathogenesis of autoimmune diseases. It is not clear 
yet whether composition (metal vs. organic components) 
and/or size of air pollution particles (PM 2.5 vs. PM < 1.0) 
affects their toxicity and capacity to induce inflammation 
and immune response to autoantigens.
The immune system – consisting of the fine-tuned 
network of humoral and cellular components – provides 
protection against microbial pathogens. The unique ability 
to discriminate between ‘self’ and ‘non-self’ allows this 
defensive network to eliminate the invading microorgan-
isms while maintaining tolerance towards autoantigens [5]. 
However, there are cases in which the system fails, and its 
malfunctioning contributes to pathological processes such 
as autoimmune diseases (ADs). Prolonged activation of 
the immune system resulting in chronic inflammation and 
tissue damage with following involvement of the adaptive 
immune system is typically observed in most ADs [6].
Autoimmune diseases have a strong genetic back-
ground involved [7, 8], but the impact of environmental 
factors must not be underestimated. Infectious agents, 
drugs as well as physical agents such as cold exposure or 
air pollution, have been considered as risk factors for either 
development or exacerbation of these conditions [6]. 
In this short review, we focus on the pathogenesis of 
ADs associated with oxidative stress in the correlation with 
particulate matter (present in air pollution), which can pro-
vide an environmental trigger for autoimmune processes.
Autoimmune diseases
Autoimmune diseases are chronic pathogenic condi-
tions embodying a heterogeneous group of disorders asso-
ciated with the loss of immunological tolerance to self-an-
tigens [8]. Affecting ca. 5% of the world population, they 
are the fourth leading cause of disability for women [9], 
who are more predisposed to suffer from them (80% of AD 
patients being female [10]). 
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The common feature that defines autoimmune diseas-
es is the breakdown of immune tolerance, leading to the 
development of the adaptive immune response to self-an-
tigens. The hallmarks of the ADs are: the presence of 
defined autoantigens, production of autoantibodies, and 
activation of autoreactive CD4+ T helper cells and self-re-
active CD8+ cytotoxic T cells along with the engagement 
of the innate immune systems components, such as phago-
cytic cells (macrophages and neutrophils) [11]. Macro-
phages take part in tissue damage by releasing reactive ox-
ygen (hydrogen peroxide, superoxide anion) and nitrogen 
species (nitric oxide). Pro-inflammatory cytokines secreted 
by macrophages recruit neutrophils and T cells to the site 
of inflammation [8]. Moreover, macrophages can drive the 
autoimmune process by phagocytosis of apoptotic/necrotic 
cells serving as a potential source of self-antigens that can 
be subsequently presented to the auto-reactive T cells.
Autoimmune diseases are usually classified into two 
groups, depending on whether the effect is organ-specific 
or systemic [8]. Systemic autoimmune disorders, such as 
rheumatoid arthritis (RA) or systemic lupus erythemato-
sus (SLE), are characterised by multi-organ involvement, 
which probably arises from the systemic distribution of 
the auto-antigens. 
Organ-specific autoimmune disorders develop when 
the immune response is directed against auto-antigens lo-
cated in a specific organ. Diabetes mellitus type 1, multiple 
sclerosis (MS), primary biliary cirrhosis (PBC), Hashimo-
to’s thyroiditis or Graves’ disease deserve to be mentioned 
among numerous organ-specific autoimmune diseases. 
What is important, the autoimmune processes which take 
part in the development of the chronic inflammatory dis-
eases mentioned above demonstrate organ-specific char-
acteristics. 
The involvement of the immune system has implied 
theories that specific proteins, which play a crucial role in 
the immunological response, may take part in the patho-
genesis of ADs. Some HLA haplotypes are considered to 
be particularly important for presentation of autoantigens 
in the autoimmune process. Thus, concurrent expression of 
both HLA-DR2 and HLA-DR3 predisposes an individual 
to development of systemic lupus erythematosus (SLE). 
Type 1 diabetes mellitus (DM) has a particularly strong 
correlation with HLA-DR3, -DR4, -DQ2, and -DQ8 [12, 
13]. People with certain alleles of HLA-DR4 are notably 
predisposed to rheumatoid arthritis (RA) [14]. Although 
genetic predilection plays a major role in autoimmunity 
(over 200 loci have been implicated in autoimmune dis-
orders), genetics cannot fully explain the patterns of these 
diseases. 
Infections [15, 16] and immune adjuvants [17, 18] are 
thought to play a crucial role in AD development or ex-
acerbation in genetically susceptible individuals [19, 20]. 
Our current studies focus on elucidating the impact of the 
inorganic chemical substances (such as transition metal ox-
ides) present in air pollution on the autoimmune processes.
Oxidative/nitrosative stress
Prolonged activation of the innate immune system and 
chronic inflammatory response are both features of ADs 
that are commonly associated with increased concentration 
of reactive species of oxygen and nitrogen that can signifi-
cantly contribute to the development of these pathogenic 
conditions.
A relatively new term of oxidative stress refers to the 
imbalance between oxidant and antioxidant molecules that 
can potentially lead to a tissue damage due to the excess of 
the former [21]. Such a situation occurs when production 
of reactive oxygen species exceeds their elimination rate 
regulated by the antioxidant system. Similarly, nitrosative 
stress has been described as a phenomenon in which the 
reactive nitrogen species in excess contribute to the patho-
genic processes [22].
The terms reactive oxygen and nitrogen species en-
compass molecules that are natural by-products of the 
normal cell metabolism. Physiologically, these molecules 
are involved in numerous processes – they are important 
for respiratory burst of phagocytic cells, cellular signalling, 
and thyroid hormone synthesis [23].
Most of the reactive oxygen species (ROS) are generat-
ed by electron leak during ATP production in mitochondria 
[24], but they can also be generated by NAPDH oxidase 
and other oxidases. Superoxide anion, hydrogen peroxide 
and hydroxyl radical are the three most important ROS in 
biological systems. Other reactive molecules such as HOCl 
(important for microbicidal activity of phagocytes) can be 
generated by reaction of hydrogen peroxide with chloride 
anion catalysed by myeloperoxidase present in azurophilic 
granules of neutrophils [25, 26].
Nitric oxide (NO) is the primary source of all reactive 
nitrogen species (RNS) present in the biological system 
[27, 28]. NO is a small signalling molecule generated by 
nitric oxide synthase, which plays a major role in vasodi-
lation and neurotransmission but is also involved in the 
antimicrobial response of the phagocytes. The nitric oxide 
potential in the pathogenesis of diseases stems from its 
reaction with superoxide, and results in formation of per-
oxynitrite, which is a potent nitrating and oxidising agent 
[29, 30].
Under physiological conditions, the concentration of 
reactive oxygen and reactive nitrogen species (RONS) is 
controlled by the scavenging system involving molecular 
and enzymatic antioxidants, which serve to maintain cel-
lular redox balance [31]. A decrease of RONS level nega-
tively affects cellular signalling [32], whereas high levels 
of RONS have been implicated in the pathogenesis of ADs 
[33, 34]. The mechanism behind this observation might 
be related not only to the initiation of pro-inflammatory 
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response, but also to the structural modification of autoan-
tigen resulting in a generation of novel, potentially auto-re-
active epitopes [35]. These alterations usually occur upon 
RONS-dependent peroxidation of lipids within the cells, 
which leads to formation of highly reactive aldehydes, 
such as malondialdehyde and 4-hydroxynonenal. These 
molecules can form covalent bonds with proteins and al-
ter both their structure and biological functions. Products 
of oxidative modification present in blood are considered 
potential biomarkers of the systemic oxidative stress, in-
flammation, and ADs [36].
Particulate matter present in air pollution
Air pollution is a mixture of gases (carbon monoxide, 
nitrates, sulphur dioxide, and ozone), aerosols, and partic-
ulate matter (solid and liquid particles) [37, 38]. There are 
two main subtypes of atmospheric particulate matter: fine 
particles and ultrafine particles. Fine particles have a di-
ameter smaller than 2.5 μm (PM 2.5), while the ultrafine 
particles have a diameter smaller than 0.1 μm [3].
Roughly-speaking, particulate matter (PM) is a com-
plex mixture of solid and liquid particles that is released 
into the air during combustion of coal, wood, gasoline, 
diesel, or fossil fuels, as well as from natural sources (road 
dust, fires, volcanic emissions, etc.) [39]. Most of the ul-
trafine particles are composed of sulphates and nitrates, 
but hydrocarbons, benzene, toluene, metals, and other 
substances can also be present in the adsorbed molecules, 
which can be inhaled by humans [2].
Human lungs make up the largest surface area exposed 
to the environmental factors present in the air. The human 
respiratory system possesses its own defensive mecha-
nisms involving components of both innate (mechanical 
mucus barrier, mucociliary clearance, and antimicrobi-
al factors) and acquired immunity (reaction to specific 
antigens with T-cell involvement) [40]. However, some 
oxidant substances constituting air pollution are likely to 
influence the physiology of the cells and either trigger or 
exacerbate the inflammatory reaction. Progressing indus-
trialisation and the growing number of motor vehicles put 
people at risk to exposure of high concentrations of such 
substances that have the capability to percolate to the upper 
respiratory tract.
Air pollution vs. autoimmune diseases
Several epidemiological studies have provided sub-
stantial evidence for the relationship between air pollu-
tion and development of autoimmune diseases [41, 42]. 
Herein, we present certain ADs and analyse the correlation 
between disease incidence and the presence of particulate 
matter in inhaled air. 
SLE is a chronic autoimmune disease characterised by 
the presence of autoantibodies, formation of immune com-
plexes, and activation of autoreactive B and T lymphocytes 
[43, 44]. Occupational exposure to silica, pesticides, sol-
vents, and other inhaled substances has been linked to its 
development [45-49]. The incidence of SLE has not been 
found to correlate with particulate matter present in the air. 
However, it seems likely that PM 2.5 may exacerbate the 
onset of the disease because they were attributed to a sig-
nificant increase of the level of anti-dsDNA antibodies, and 
the presence of the renal casts in SLE patients [50].
Diabetes mellitus type 1 can be characterised by to-
tal deficiency of insulin release by the β-cells of pancre-
as, which are destroyed in the autoimmune process [51]. 
The root cause of DM type 1 remains unknown, but some 
studies suggest that a combination of genetic and environ-
mental factors is involved. Exposure to ozone, sulphates, 
and other pollutants present in the air has been associated 
with type 1 diabetes in children [52, 53]. Air pollution was 
found to increase the risk of acute complications of diabe-
tes demanding hospitalisation [54]. Nevertheless, there are 
only a few reports suggesting that air pollution increases 
mortality among diabetics [55-57].
Rheumatoid arthritis is a systemic autoimmune disease 
characterised by multi-system inflammation [58-60]. Both 
genetic and environmental factors have been implicated in 
its development; however, the mechanism through which 
the environmental triggers might affect the disease has not 
been elucidated [61]. Both tobacco smoking and exposure 
to silica have been associated with higher risk of develop-
ing RA [62-66]. High concentration of PM 2.5 has been 
shown to increase the risk of juvenile idiopathic arthritis 
among young children by 60% [67]. Similarly, exposure to 
PM 2.5 has been associated with the prevalence of system-
ic RA [61, 68]. Furthermore, the analyses performed by the 
Nurses’ Health Study in 2009 [69] suggest that pollution 
emissions from road traffic may be an environmental fac-
tor responsible for exacerbation of RA. 
Association between air pollution and autoimmunity 
has also been found for multiple sclerosis (MS) – increased 
concentration of pollutants in the air (PM10 as well as SO
2
 
+ NO
2
 + NO) was correlated with relapses of the disease 
[42]. The potential association between MS occurrence and 
air pollution was implied following the study in the state 
of Georgia, US [70]. These findings were later confirmed 
by similar studies performed in Iran, Serbia, France, and 
Italy – demonstrating that MS occurrence and hospitalisa-
tion was associated with exposure to air pollutants such as 
PM10, SO
2
, NO
2
, and NOx [71-74].
From air pollution to autoimmune process
The mechanisms behind the relationship between poor 
air quality and AD prevalence and exacerbation are still 
unclear. While the local impact of inhaled air pollution 
particles on lung injury might seem obvious, it is not ev-
ident how they can affect other remote tissues to initiate 
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autoimmune processes (how they can prime autoimmune 
processes in other remote tissues). Several hypotheses sug-
gest activation of the systemic inflammatory response via 
oxidative/nitrosative stress, as well as the enhanced presen-
tation of oxidative-modified autoantigens [75, 76].
When PMs are inhaled, some oxidants are generated 
locally in lung alveoli, where they may cause local chronic 
inflammation. However, the correlation between air pol-
lution, the lung, and chronic inflammation has not been 
well examined [36]. The key to explain the role of lung 
in systemic inflammation lies in understanding the mech-
anism of modification of the biomolecules produced by 
inhaled oxidants (PM components), or generated by in-
flammatory cells in the upper and lower airways (alveolar 
macrophages) [77, 78]. Oxidised biomolecules are more 
susceptible to degradation, but they can also inhibit the 
removal of oxidatively modified proteins via the protea-
some system [79].
The effect of inhaled nanoparticles (PM) on human 
health depends on both individual predisposition (such 
as genetic factors) and PM properties [80]. The opinion 
that a particle’s toxicity depends on its size, shape, and 
composition is broadly accepted [81]. Importantly, the ox-
idative stress can result from Fenton-type reactions cata-
lysed by the transition metal present in particles, such as 
Fe, V, Cr, Co, Ni, Cu, Zn, and Ti [82], but other metals 
and non-metals can also exert negative effects on the cells. 
For example, silica particles are toxic to macrophages [83-
85] and induce cell death causing exposure of intracellular 
self-antigens to immune cells [86, 87]. In murine models 
of silica exposure an increase in the production of autoan-
tibodies and formation of autoantibody immune complexes 
was observed [88, 89], as well as an increase in numbers 
of B-lymphocytes and CD4 T cells [90]. All these factors 
might contribute to chronic lung inflammation and have 
been reported as possible risk factors for development of 
autoimmune diseases, such as RA and SLE [91]. 
It has been shown that environmental exposure to as-
bestos particularly increases the risk of autoimmune dis-
eases [92, 93]. In turn, exposure to iron and other transition 
metals can result in generation of reactive oxygen species 
on the lung cells surface, which may cause injury and lead 
to formation of scar tissue [94]. 
Numerous studies have revealed a negative impact of 
inhalation of air pollutants on human health. In general, 
particulate matter (PM) affects the upper bronchi, and this 
may lead to pulmonary inflammation [95]. Nanoparticles 
are considered even more dangerous than large size par-
ticles because they are more difficult to remove from the 
human body by the organism itself. Due to their small size, 
nanoparticles penetrate easily via the respiratory tract into 
the biological structures and disrupt their functions by 
driving oxidative stress and contributing to tissue inflam-
mation [80].
Inhalation of nanoparticles has been shown to stimulate 
alveolar macrophages, creating conditions for development 
of an acute systemic inflammatory response [37, 96, 97]. 
Airway inflammation, a major short-term effect of inha-
lation of the particles present in the polluted air [98], is 
characterised by an increased secretion of pro-inflammato-
ry mediators like interleukin-8 [99] and granulocyte mac-
rophage-colony stimulating factor (GM-CSF), as well as 
by neutrophil influx [100, 101]. Inflammatory cells, neu-
trophils, and macrophages, generate a variety of reactive 
oxygen and nitrogen species and release various proteases 
that damage lung tissue [22]. Then, following the fine and 
ultrafine particles’ passage into the blood, exposure to PM 
can potentially trigger a systemic inflammatory process 
[95] via induction of ROS production and pro-inflamma-
tory cytokine release [102, 103].
It seems plausible that generation of soluble inflam-
matory mediators in the lungs upon PM inhalation might 
have a systemic impact. Systemic oxidative stress [104, 
105], stimulation of the bone marrow [97, 106, 107], and 
increased levels of cytokines and leukocytes in blood have 
all been associated with exposure to air pollutants [108, 
109]. Furthermore, air pollution has been shown to induce 
maturation of antigen presenting cells by inducing expres-
sion of costimulatory molecules [110-116]. Particulate 
matter present in the air can also act as an adjuvant and 
induce immune response against otherwise non-immuno-
genic antigens in several animal models [101, 117-119]. 
Animal studies have also provided evidence that exposure 
to particulate matter can have glycaemic consequences in 
a gestational diabetes mellitus rat model [120].
Therefore, air pollution could affect the autoimmune 
processes in multiple ways. Induction of oxidative/nitrosa-
tive stress can lead to production of autoantigens (via oxi-
dative modification) and additionally to the stimulation of 
the release of soluble inflammatory mediators (cytokines) 
that can trigger maturation of antigen-presenting cells [75]. 
APCs migrating to the lymph nodes could thus present the 
self-antigens to the lymphocytes that had evaded the mech-
anisms of central tolerance. Upon establishment of the au-
toimmune reaction, pro-inflammatory cytokines that are 
released following continuous inhalation of the pollutants 
could additionally exacerbate the process.
Conclusions 
Autoimmune diseases are among the most crucial 
challenges of current medicine. They still cause chronic 
disability and mortality of patients with pulmonary and 
cardiovascular diseases. Currently, it has been accepted 
that particulate matter can contribute to autoimmunity by 
complex interactions between genetic, environmental, and 
epigenetic factors. However, the exact molecular mecha-
nisms by which chemicals contained in air pollution affect 
autoimmunity are still unknown. Particulate matter present 
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in air pollution can induce oxidative stress and cell death, 
both by apoptosis and necrosis of human cells leading to 
aggravation of chronic inflammation, i.e. the tissue damag-
ing reaction observed in autoimmune diseases. Therefore, 
identification of strong inducers of oxidative stress among 
components of PM seems to be crucial for their neutralisa-
tion and elimination from the ambient environment.
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